Skip to content
Research Article Open access CC BY 4.0

Estimation of Quality Adjusted Life Years (QALYs) for HIV Patients on Art in Kenya Using Proxy Utility Function

Winnie Chacha, Jane Akinyi, Samuel Mwalili

Asian Journal of Probability and Statistics · pp. 8–15 · Published 15 Sep 2022

10.9734/ajpas/2022/v20i130479

Abstract

Aims: This study seeks to estimate QALYs for HIV/AIDS patients on ART in Kenya to quantitatively evaluate the health impact of ART treatment on patients. QALYs values are important as they form a                 basis for evidence based decision making and policy formulation in the country with regards to HIV/               AIDS. Study Design: The study involved secondary data obtained from a retrospective follow up study on hospital records of HIV/AIDS patients enrolled for ART from 2005 to 2017. Place and Duration of Study: Jomo Kenyatta University of Agriculture and Technology, between January 2019-April 2022. Methodology: The study involved a retrospective study of 3000 patients on ART in Kenya from the period of 2005-2017. All the patient records are identified using random patient id ensuring the privacy and anonymity of patients. The inclusion criteria is patients who had complete information on the covariates used in the model during follow up. The joint modelling of the longitudinal and survival data of each patient was applied and the results applied to proxy utility function to estimate the QALYs for patients on ART. To get the average QALYs gained by all patients, we aggregate the total QALYs from each patient. R. Software version 4.0.2 was used in the analysis. Results: Sex, age, Marital Status and weight are significant predictors of survival of HIV Patients on ART in Kenya. Being on ART therapy resulted in a gain of 9.688313 QALYs for HIV/AIDS patients. The association parameter estimate is-0.0345 implying that increase in the values of CD4 count results in a decrease in the hazard of death for HIV patients on ART therapy. Conclusion: The proxy utility function methodology is appropriate for the calculation of QALYs values for HIV patients on ART. It has the advantage of allowing utilities of each patient to vary and are calculated at every time point. Since ART results in the improvement in QALYs of patients, efforts should be directed towards ensuring patients who are enrolled for the therapy continue with it for sustained health and non health benefits.

Effectiveness health survival covariates

References (17)

  1. 1 The estimation of a preference-based measure of health from the SF-36 [DOI]
  2. 2 HALYs and QALYs and DALYs, Oh My: Similarities and Differences in Summary Measures of Population Health [DOI]
  3. 3 EuroQol-5D (EQ-5D): an instrument for measuring quality of life [DOI]
  4. 4 Fallacy of the log-normal approximation to optimal portfolio decision-making over many periods [DOI]
  5. 5 Global Epidemiology of HIV/AIDS: A Resurgence in North America and Europe [DOI]
  6. 6 Health economic evaluation: Important principles and methodology [DOI]
  7. 7 QALYs in 2018—Advantages and Concerns [DOI]
  8. 8 Joint modelling of accelerated failure time and longitudinal data [DOI]
  9. 9 Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy [DOI]
  10. 10 QALYs as a measure of value in cancer [DOI]
  11. 11 A Note on QALYs, Time Tradeoff, and Discounting [DOI]
  12. 12 Donor Support and the Impacts on Health System Strengthening in Sub-Saharan Africa: Assessing the Evidence through a Review of the Literature [DOI]
  13. 13 A Multistate Markov Model Based on CD4 Cell Count for HIV/AIDS Patients on Antiretroviral Therapy (ART) [DOI]
  14. 14 Time-homogeneous Markov process for HIV/AIDS progression under a combination treatment therapy: cohort study, South Africa [DOI]
  15. 15 Estimating trends in life expectancy in HIV-positive individuals [DOI]
  16. 16 A New Approach to Evaluate Quality Adjusted Life Years using Proxy Utility Function - An Application to HIV/ AIDS Data [DOI]
  17. 17 Using QALYs in Cancer: Review of the Methodological Limitations

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

47

Page views

0

PDF downloads

6

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.